Pricing built for enterprise healthcare decisions
Start free, pilot with proof, then expand only when the value is clear.
SCRIMED is priced to be easy to evaluate and serious to buy: free public demos, paid workflow assessments, synthetic pilots, protected enterprise pilots, annual operating licenses, and strategic partnerships for organizations ready to scale.
Recommended model
Hybrid enterprise model: free public preview, paid assessment, paid synthetic pilot, protected enterprise pilot, annual platform license, and custom strategic partnerships.
SCRIMED pricing and sales motions currently sell governed synthetic evaluations, readiness assessments, and protected enterprise pilots. Pricing does not imply live clinical execution, autonomous diagnosis, payer submission, reimbursement guarantees, or production medical-record processing.
Premium pricing posture
Price SCRIMED like trusted healthcare intelligence infrastructure.
Protect enterprise price integrity
Use starts-at floors and scoped enterprise ranges; do not publish low monthly plans for the operating layer.
- SCRIMED sells governed healthcare intelligence infrastructure, workflow transformation, trust controls, and enterprise proof, not a commodity chatbot seat.
- Discount only by reducing scope, duration, services, integrations, or support commitments.
Price against workflow value and governance scope
Anchor fees to workflows under governance, departments served, integrations, support level, security review, and proof-stack depth.
- Healthcare buyers pay for measurable operational intelligence, trusted controls, and deployment readiness across high-friction workflows.
- Measured pilot outcomes are directional business evidence, not guaranteed clinical, payer, or reimbursement outcomes.
Separate platform license from implementation services
Keep annual platform licensing distinct from assessment, pilot, connector, migration, security, training, and advisory work.
- This preserves SCRIMED's long-term platform margin while making complex enterprise delivery transparent to buyers.
- Live connector, PHI, clinical, payer, or sovereign deployment work requires approved written scope and controls.
Move qualified buyers toward multi-year commitments
Use paid assessments and synthetic pilots to validate scope, then convert protected pilots into annual or multi-year platform agreements.
- Enterprise healthcare transformation compounds through trust, workflow ownership, integrations, and institutional memory.
- No customer should enter production use without legal, privacy, security, governance, and human-review approvals.
Pricing tiers
Pick the buying motion that matches your readiness, urgency, and governance burden.
Public Product Preview
Website visitors, investors, advisors, and early enterprise evaluators
- Qualified buyer moves from education to pilot intake.
- Expansion: Synthetic Pilot Evaluation
- Public preview is a product education surface, not a live clinical system.
Workflow Intelligence Assessment
Hospitals, clinics, payers, and transformation teams validating workflow opportunity before a pilot
- Buyer approves pilot scope, value hypothesis, and governance gates.
- Expansion: Synthetic Pilot Evaluation or AI Readiness + Governance Audit
- Assessment produces operational intelligence for human leaders; it is not clinical advice.
Synthetic Pilot Evaluation
Enterprise buyers who want to evaluate SCRIMED against synthetic workflows before live integration
- Buyer validates workflow value, trust posture, and protected-pilot business case.
- Expansion: Protected Enterprise Pilot
- Synthetic data only; no diagnosis, treatment, payer submission, or patient outreach.
Protected Enterprise Pilot
Health systems, payers, public-sector programs, and enterprise operators preparing controlled deployment
- Buyer approves annual operating license, connector scope, and governed production plan.
- Expansion: Enterprise Operating License
- Protected pilot still requires human review and approved controls before any live clinical workflow use.
Enterprise Operating License
Large hospitals, payers, government health agencies, and multi-site healthcare organizations
- Multi-workflow expansion with measurable operational value and governed trust posture.
- Expansion: Strategic Platform Partnership
- Production use requires signed controls, approved workflows, and human-review operating procedures.
Strategic Platform Partnership
Governments, national health systems, major payers, strategic hospital networks, and global partners
- SCRIMED becomes a governed healthcare intelligence infrastructure partner.
- Expansion: Regional or ecosystem-level deployment
- Strategic work remains governed, auditable, human-reviewed, and regionally compliant.
Market alignment
Use competitor prices as context, then defend SCRIMED's premium through enterprise proof and governance.
Keep public demos free, guided standard demos no-cost for qualified buyers, assessments at $25k-$150k depending on scope, synthetic pilots at $125k-$500k, protected pilots at $400k-$2M+, annual licenses at $1.5M-$12M+, and strategic partnerships at $8M-$25M+.
Public demos
Keep free, no-PHI, no-account public demos and qualified standard guided demos.
- Custom prep, questionnaires, buyer-specific proof packets, and diligence release work move into paid scope.
Assessments
Use $25k-$75k as the standard assessment band, with a $12.5k-$25k mission-clinic access path and $75k-$150k enterprise assessment band.
- Cap workflow count, meetings, artifacts, and review cycles; discount only by reducing scope.
Synthetic pilots
Use $125k-$350k as the standard 45-90 day synthetic pilot band and $350k-$500k for expanded proof scope.
- Separate custom packets, protected workspaces, integration planning, legal/security diligence, and implementation labor.
Protected enterprise pilots
Use $400k-$1.25M as the standard 90-180 day protected pilot band and $1.25M-$2M+ for multi-site or heavy diligence scope.
- Separate annual license, services, support, model usage, evidence-room release, connector work, and change orders.
Enterprise operating license
Use $1.5M-$6M annual for initial enterprise layer and $6M-$12M+ for multi-department or multi-region expansion.
- Keep implementation, support, connector, usage, and continuous review retainers out of the base license unless explicitly priced.
Current market context
SCRIMED is not priced as a commodity monthly scribe seat.
Freed, Tali, and Heidi show free or low monthly clinician entry points for narrow documentation workflows.
SCRIMED should not compete as a low-cost per-seat scribe; free demos are the entry point, while paid work is enterprise workflow, governance, interoperability, and proof packaging.
- Public competitor pricing pages and plan pages
Suki, Ambience, Abridge, and similar vendors lead with workflow breadth, EHR adjacency, specialty support, and sales-led enterprise pricing.
SCRIMED pilot pricing should scale by workflow family, departments, governance burden, proof depth, implementation complexity, and protected controls.
- Public enterprise product pages and case-study positioning
Redox-style integration platforms use custom pricing because EHR connectivity, uptime, security, data exchange, and trading-partner requirements drive cost.
Connector and production data-exchange work must remain outside standard demo and synthetic-pilot prices until separately reviewed and priced.
- Public healthcare integration product and pricing-positioning pages
The 2026 Berta open-source scribe paper reports commercial AI scribes at $99-$600 per physician per month and internal operating costs below $30 per physician per month.
SCRIMED must defend enterprise price through proof, governance, safety, workflow redesign, interoperability readiness, and margin-transparent implementation.
- Berta arXiv paper
Sales motion
Move from website interest to a funded pilot without custom-scope confusion.
Website to Product
Buyer learns the brand on Wix and clicks into the SCRIMED product app.
- Route buyer to Product Console, Pricing, Evaluation, or Pilot Intake.
- Buyer has healthcare workflow, governance, interoperability, or AI readiness need.
- Run evaluation or submit pilot intake.
Self-Guided Product Evaluation
Buyer inspects synthetic AgentOS/Atlas outputs without needing Vercel or an account.
- Package product proof around task plans, Trust Cards, audit preview, and observability.
- Buyer confirms one or more high-value workflows and a sponsor.
- Paid assessment or synthetic pilot.
Paid Evaluation or Synthetic Pilot
Buyer reviews the Pilot Deal Room, requests scoped assessment or pilot, and acknowledges no-PHI boundary.
- Qualify buyer, define scope, metrics, governance gates, decision criteria, and deal-room packet.
- Sponsor, budget range, workflow owner, review team, and pilot success metrics exist.
- Protected pilot or annual license proposal.
Protected Pilot to Enterprise License
Buyer reviews implementation, security, compliance, and annual operating model.
- Propose base platform license plus workflow, connector, agent, support, and usage scope.
- BAA, identity, audit, connector, security, and human-review controls approved.
- Annual enterprise agreement.
Enterprise Expansion
Buyer expands from one workflow to multiple departments, regions, or organizations.
- Use observability, trust metrics, and governance reporting to support expansion.
- Measured value and safety posture remain strong under review.
- Multi-year strategic partnership.
Value metrics
Price against workflow value, governance scope, and deployment complexity.
Workflows under governance
Healthcare buyers buy workflow transformation, not generic AI usage.
- Workflow expansion requires approved human-review and audit controls.
Agent and service modules enabled
Sanar AI, DocuTwin, CareExplain, Ambient Scribe, TrialCore, PayerIQ, and future services carry different value and risk.
- No module implies autonomous diagnosis, treatment, payer submission, or patient outreach.
Connector and integration scope
EHR, payer, CRM, knowledge, and analytics connectors drive implementation cost and enterprise value.
- Live connectors require BAA, tenant identity, audit, security, and approval controls.
Evaluation and task volume
AI-heavy usage should scale with actual activity without surprising buyers.
- Usage pricing should be capped or contracted to preserve buyer trust.
Organizations, regions, and departments
SCRIMED can expand from department workflow to enterprise operating layer.
- Regional compliance, data residency, language, and governance needs must be explicit.
Commercial guardrails
Sales should increase trust, not create clinical or regulatory overclaim risk.
Do not publish low consumer-style pricing
SCRIMED is an enterprise healthcare operating layer. Public pricing should show package ranges or 'starts at' for evaluations, with enterprise pilots handled by sales.
Sell outcomes as measured pilot signals
Use time saved, workflow friction, denial risk, access bottlenecks, documentation quality, and trust completeness as pilot metrics, not unsupported clinical claims.
Separate public preview from paid pilots
Website visitors can inspect the product, but paid assessments and pilots require sponsor, workflow scope, governance needs, and no-PHI acknowledgement.
Keep medical-device and clinical claims out of sales copy
SCRIMED should present as governed operational intelligence until clinical, regulatory, and production execution controls are explicitly approved.
Use enterprise sales with sales engineering
Healthcare buyers need security, compliance, workflow, interoperability, ROI, and trust review before annual license commitment.